Oral Glucose Tolerance Testing After Gestational Diabetes
This trial is active, not recruiting.
|Conditions||gestational diabetes, pregnancy, obesity|
|Sponsor||MetroHealth Medical Center|
|Collaborator||Centers for Disease Control and Prevention|
|Start date||October 2012|
|End date||May 2016|
|Trial size||150 participants|
|Trial identifier||NCT02082301, MH-IRB12-00581|
This is an observation study of women with gestational diabetes. Subjects recruited undergo immediate postpartum diabetic screening prior to discharge. Post-partum screening for overt diabetes is repeated 6-12 weeks postpartum. The outcome of interest is the utility of an immediate post partum screen for overt diabetes compared to a traditional 6 week test.
Primary cohort is women with diagnosis of gestational diabetes without evidence of overt diabetes
Primary outcome: sensitivity of immediate post partum screen
time frame: Immediate post partum
Secondary outcome: physiology
time frame: 3 time points: antepatum, immediate postpartum, 6 weeks post partum
Female participants at least 18 years old.
Inclusion Criteria: - Singleton pregnancy - Gestational diabetes Exclusion Criteria: - Multiple gestations - pre-pregnancy diabetes
|Official title||Oral Glucose Tolerance Testing After Gestational Diabetes|
|Principal investigator||Thaddeus Waters, MD|
Call for more information